SlideShare a Scribd company logo
NATURAL HISTORY OF
ASD/ VSD/ PDA
Dr. Murtaza Kamal
MBBS, MD, DNB
DNB SS RESIDENT (PEDIATRIC CARDIOLOGY)
murtaza.vmmc@gmail.com
DOP:031017
1
VSD
2
INCIDENCE
 Most common CHD
 Isolated VSD: 20 – 30% of all CHD
 Echo studies: 5-50/1,000 newborns [1]
 No sex preference
1. Ooshima A et al. Cardiology 1995;86:402-406.
3
CLASSIFICATION OF VSD
Soto et al classification of VSD
 Perimembranous (membranous/ infracristal ): 70-80%
 Muscular: 5-20%
 Central- mid muscular
 Apical
 Marginal- along RV septal junction
 Swiss cheese septum – multiple defects
 Inlet/ AV canal type: 5-8%
 Supracrital (Conal/ infundibular/subpulmonary/doubly
committed subarterial): 5-7%
Benigno soto et al. Br HeartJ 1980; 43: 332-343
4
HAEMODYNAMIC CLASSIFICATION
5
Perloff’s Clinical Recognition of CHD 6th Edition
FACTORS INFLUENCING OUTCOMES &
NATURAL HISTORY OF VSD
Position & Size
Number of defects
Anatomic structures in the vicinity of the
defect
Association of other malformation
Age at which the defect is recognized
Sex of the patient
6
NATURAL HISTORY: VSD
 Cardiac failure
 Spontaneous diminution in size or closure
 Right or Left ventricular outflow tract obstruction
 Aortic regurgitation
 Pulmonary vascular obstructive disease
 Infective endocarditis
7
1. CARDIAC FAILURE
8
CARDIAC FAILURE (CONT.)
Rare in small VSD as size limits the L-R shunt
 In large VSD the relative resistances of the systemic
and pulmonary circulations regulate flow
 Shunt occurs mainly in systole
 Shunt directly to PA
 Enlargement of LA, LV, PA 9
CARDIAC FAILURE (CONT.)
 Moderate sized VSD: Symptoms by 3- 6 months
 Large VSD: CHF in first few weeks
 Risk for recurrent pulmonary infection high, failure to
thrive
 If survives without therapy: Pulmonary vascular disease
develops in the first few years of life
 Rudolph AM, et al.Pediatrics 1965;36:763-772
10
2. SPONTANEOUS DIMINUTION IN SIZE
 Occurs in both: Perimembranous+ muscular
 Closure documented in fetus and adults
 VSD diagnosed in the fetus: 46% (in utero closed),
23.1% (closed in 1st YOL), 30.8% (remained patent)
 15.8% of defects <3mm, 71.4% of defects >3mm:
remained patent at 1YOL
 None of the malaligned defects closed
 69% of the perimembranous defects and 60% of
muscular trabecular defects closed spontaneously
11
*Nir A et al.Pediatr Cardiol 1990; 11: 208–10
SPONTANEOUS DIMINUTION IN SIZE
(CONT.)
12
More common in <10 years of age
75% of small VSDs and 83% of muscular defects close
spontaneously by 10 years of age[1]
1. Alpert BS et al., Spontaneous closure of small ventricular septal defects: ten-year follow-up. Pediatrics 1979; 63:
204–6
SPONTANEOUS DIMINUTION IN SIZE
(CONT.)
.
 Spontaneous closure decreases substantially
after 1 year of age
 Female predominance
 1. Moe DG, Guntheroth WG. Spontaneous closure of uncomplicated ventricular septal defect.
Am J Cardiol 1987; 60: 674–8.
 2. Farina MA et al . J Pediatr 1978; 93: 1065–6.
13
SPONTANEOUS DIMINUTION IN SIZE
(CONT.)
 During adolescence -- diminution in size of the defect in
> 20%[1]
 VSD can even close in the adults: [2]
Spontaneous closure
 In 10% of 188 adults
17 to 45 years
Followed for a mean of 13 years
 1. Onat T, Ahunbay G, Batmaz G, Celebi A.The natural course of isolated ventricular septal defect during
adolescence. Pediatr Cardiol 1998; 19: 230–4.
2. Neumayer U, Stone S, Somerville J. Small ventricular septal defects in adults. Eur Heart J 1998
14
SPONTANEOUS DIMINUTION IN SIZE
(CONT.)
 Malaligned VSD rarely undergoes spontaneous
closure or diminution in size
Only in 4% of patients
All of the defects were initially < 4 mm in
diameter
Tomita H, Arakaki Y,Yagihara T, Echigo S. Incidence of spontaneous closure of outlet ventricular
septal defect. Jpn Circ J 2001; 65: 364–6.
15
MECHANISMS OF SPONTANEOUS
CLOSURE OF VSD
16
A. Closure of a perimembranous defect by adhesion of the tricuspid leaflets to the defect margin.
B. Closure of a small muscular defect by a fibrous tissue plug.
C. Closure of a muscular defect by hypertrophied muscle bundles in the right ventricle
D. Closure of a defect in subaortic location by adhesion of the prolapsed aortic valve cusp
E. Aneurysmal transformation of the membranous septum
3. RVOT OBSTRUCTION
 Incidence: 3-7%
 Mechanism:
 Hypertrophy of malaligned infundibular septum
 Hypertrophy of right ventricular muscle bundles
 Prolapsing aortic valve leaflet
High incidence in:
 Rt sided aortic arch
 Horizontal RVOT
Varghese PJ et al . Br Heart J 1970; 32: 537–46
Tyrrell MJ et al. Circulation 1970; 41 & 42(Suppl. III): 113
17
AORTIC VALVE PROLAPSE
 VSD with direct contact with aortic valve are most
prone to develop AVP:
All perimembranous defects
All doubly committed juxta arterial defects
Most of muscular outlet defects
Prevalence of AOP (2-7%)
Rare before age of 2 years
Nadas AS et al . Circulation 1977; 56(No.2, Suppl. I): 1–87.
18
AORTIC VALVE PROLAPSE (CONT.)
 RCC (60-70%), NCC (10-15%), Both (10-20%),
LCC (extremely rare)
 NCC prolapses in perimembranous type VSD
 AR may be due to incompetent bicuspid valve
 Prolapsed valve may perforate rarely
19
AORTIC VALVE PROLAPSE (CONT.)
 Aortic regurgitation: 10%
 Increases with age
 Infundibular VSD vs membranous VSD – RR 2.5
 AR is progressive , so early surgical intervention
needed
 Momma K, Toyama K, Takao A, et al. Natural history of subarterial infundibular ventricular septal defect.
Am Heart J 1984; 108:1312
20
AORTIC VALVE PROLAPSE (CONT.)
21
AORTIC VALVE PROLAPSE (CONT.)
22
Parasternal long-axis echocardiogram view showing supracristal ventricular septal
defect (arrow) with buckling and prolapse of the right coronary cusp of the aortic
valve.
VSD WITH AI- INDIAN SCENARIO
 Sample size: 362, 37(10.2%) had AI
 Mean age: 13.4 y (2-45yrs), M:F::5:1
 31(84%): Infracristal; 6(16%): Supracristal VSDs
 In infracristal VSD: RCC prolapse:14(48%);
NCC: 12(41%); Both: 3(11%)
 In supracristal VSD: RCC prolapse: 5(83%);
NCC prolapse: 1(17%)
 2 patients, AR due to bicuspid aortic valve
 No relationship- severity of AR & location of VSD
 Somanath HS et al. Indian Heart J. 1990 Mar-Apr;42(2):113-6.
23
INTERVENTION IN VSD WITH AVP
 Indicated for both perimembranous and subarterial
VSDs when more than trivial AI
 Subarterial VSDs >5mm: Closed regardless of AVP
 Restrictive perimembranous VSD with AVP but
without AI, surgery indications less clear:
Regular follow up
Surgery indicated only if AI develops
 1. Elgamal MA et al . Ann Thorac Surg 68:1350-1355, 1999
2. Lun K et al. Am J Cardiol 87:1266-1270, 2001
3. Gabriel HM et al. J Am Coll Cardiol 39:1066-1071, 2002
24
LVOT OBSTRUCTION
 Usually above the defect and occasionally below
 May be evident from immediate post natal period
 Progression of the pre-existing lesion or can be
acquired
 Obstruction is either muscular of fibromuscular
Starnes SL et al. Thorac Cardiovasc Surg 2001; 122: 518–23., Liu SP et al. Endothelion 1994; 2: 11–33
25
4. PULMONARY VASCULAR OBSTRUCTION
 Incidence: 5-22%[1]
 Rare in small and moderate sized VSDs
 Mechanism: Excessive pulmonary blood flow Vessel
injury Thick adventitia, medial hypertrophy, intimal injury[2]
 Down syndrome babies develop PAH early
 No sex predilection
 Infants with VSD and increased pulmonary arterial pressure-
repair between 3-12 months
 1. Keith JD et al. Heart Disease in Infancy and Childhood. 1978: 320–79
 2. Wilkinson JL.. Ped Cardiovascular Med. 2000;289–09
 3. DuShane JW, et al.The Child with CHD after Surgery. Futura Publ.1976
26
5. INFECTIVE ENDOCARDITIS
 18.7 per 10,000 person years in non operated
cases
 Operated VSDs: 7.3 per 10,000 person-years
 Higher in small defect and lower during childhood
 Age >20years and male sex are other risk factors
Gersony WM et al.Circulation 1993; 87(Suppl. I):I-121–I-126
27
INFECTIVE ENDOCARDITIS (CONT.)
 TEE: Diagnostic procedure of choice
 Membranous VSD: Vegetation on the tricuspid valve
 Infundibular defects: Aortic or pulmonary valve vegetation
 ACC/AHA : No antibiotic prophylaxis for the acyanotic
uncomplicated VSD with no prior history of endocarditis
 Patients with a proven episode of endocarditis: Increased risk of
recurrent infections, so surgical closure may be recommendedtion
so surgical closure may be recommended 28
ENDOCARDITIS PROPHYLAXIS
 The 2007 guidelines of the AHA recommend no antibiotic
prophylaxis in children with an isolated VSD except :
 During the first six months after the repair with prosthetic
material or device
 Repaired VSD with a residual defect at the site or adjacent to
the site of a prosthetic device
 Prophylactic antibiotics is recommended for dental and
respiratory tract procedures 29
6. ARRHYTHMIAS
 Presenting signs of VSD in adults
 Ventricular tachycardias : 5.7 %
 Sudden death: 4.0 %
 Age and pulmonary artery pressure: Best predictors for
ventricular arrhythmias
 Assess for candidacy for VSD repair in all adults with VSD and
cardiac arrhythmias
1. Wolfe RR et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and
ventricular septal defect. Results of 24-hour ECG monitoring. Circulation 1993; 87:I89.
30
ARRHYTHMIAS (CONT.)
 VSD with Eisenmenger syndrome:
 VT: 19%
 Hypertrophied RV : Ideal for ventricular arrhythmias
 Atrial fibrillation:
 Prevalent in adult VSD
 Risk factors:
Increasing age
LV dysfunction
Elevated PA pressure
 Kidd L et al. Second natural history study of congenital heart defects. Results of treatment of
patients with ventricular septal defects. Circulation 1993; 87:I38 31
CAUSES OF IMPROVEMENT IN SYMPTOMS
OF VSD
 Closing defect: Soft S2
 Increasing PVR: Increased RV pulsations, parasternal
heave, S2 loud
 Infundibular hypertrophy & resulting decreased L to R
shunt: S2 decreases in intensity ,crescendo-
decrescendo systolic murmur in the ULSB
 Cyanosis (shunt reversal )
32
COURSE OF A SMALL VSD
33
PREGNANCY AND VSD
 Mother: Cardiac complications rare
 No events of arrhythmias, heart failure
 Cardiovascular events (MI, stroke, CV mortality): 1%
 Fetus
 Preterm delivery :11.7%
 Fetal mortality : 1.3%
 Recurrent congenital heart disease of any type : 2.7%
Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart
disease: a literature review. J Am Coll Cardiol 2007; 49:2303
34
NATURAL HISTORY OF CHD STUDIES
35
VSD: NATURAL HISTORY IN A NUTSHELL
36
Perloff 5th edition
PDA
37
INTRODUCTION
 Functional closure in term infants within 10–15 h
 <30 weeks gestation : PDA persists D4OL in 65 %
 Anatomical closure is usually complete: 3months
 PDA-Continued patency in infants older than 3 months
 Incidence : 5.3–11.0% (median 7.1%) of all congenital cardiac
lesions
 Casseles DE. The ductus arteriosus. 1973:91
38
INTRODUCTION (CONT.)
 2.9 per 10,000 live births (population-based study of
400,000 term infants)[1]
Isolated PDA among term infants - 0.03 to 0.08 %[2]
 In very low birth weight infants (< 1500 g) - 30 %[3]
1. Reller MD et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr
2008; 153:807
2. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39:1890
3. Lemons JA et al. Very low birth weight outcomes of the NICHD Neona 39
INTRODUCTION (CONT.)
Incidence of silent ductus not known
(0.1–0.2% of the population may be affected)
 Incidence of re-patency of the arterial duct after initial
closure: 0.9%[1]
 Incidence of isolated PDA in term infants: 1 in 2,000[2]
 Female predominance - 3:1 (except in congenital
rubella)[3]
 1. Raaijmaakers B etal., Difficulties generated by the small, permanently patent, arterial duct. Cardiol
Young 1999; 9: 392–5.
 2. Carlgren LE et al. Br Heart J. 1959;21:40 –50.
 3. Zetterquist P et al. University of Uppsala, Sweden 1972 40
INTRODUCTION (CONT.)
 High incidence in:
Maternal rubella
Preterms, LBW babies:
<1750g: 50%
<1200g: 80%[1]
 Teratogens (18-60 days of gestation): Alcohol/
amphitamines/ phenytoin
 Siblings have increased risk (2-4%)
 1. Gibson S et al. Am J Dis Child. 1952;83:117–119.
41
NATURAL HISTORY
 Depends on:
Size and magnitude of shunt
Status of pulmonary vasculature
42
SIZE OF PDA
SMALL MODERATE LARGE
Mostly asymptomatic LV volume overload LV volume overload
and cardiac failure at
3 months of age
Increased risk of
endarteritis
Rarely rhythm
disturbances like atrial
fibrillation
Increased pulmonary
resistance
Eisenmenger’s
syndrome occurs by
1st decade
43
NATURAL HISTORY
 Congestive heart failure
 Infective endarteritis
 Pulmonary vascular disease
 Aneurysmal formation
 Thromboembolism
 Calcification
44
CONGESTIVE HEART FAILURE
 Clinical course is similar as VSD
 Depends on size, magnitude of shunt & the status of the
pulmonary vasculature
 CHF develops in infancy or during adult life
 Heart failure in infancy usually occurs before 3 months
of age
 Commonest cause of death
 Initially lt heart failure, later right heart failure
45
INFECTIVE ENDARTERITIS
 Incidence: 1% per year
 Decreased dramatically since the early natural
history studies before the era of routine surgical
closure and antibiotic usage
 Vegetations usually occur on PA end, embolic
events usually of the lungs rather than systemic
circulation
 Perloff 5TH edition
46
PULMONARY VASCULAR DISEASE
 Large PDA if defect not repaired
 No definite data on incidence
 Differential cyanosis
 Non restrictive PDA, Eisenmenger’s develops by 1st
decade
 Eisenmenger patients do no tolerate PDA closure
47
PULMONARY VASCULAR DISEASE (CONT.)
 PDA: Relatively common cause of PAH of unknown cause
in adolescents and adults
 In one series of 24 patients, 16 had a left-to-right shunt
with PAH of unexplained cause:
ASD in 8
PDA in 6
VSD in 2
In this series these lesions were best detected by
transesophageal echocardiography
Chen WJ, Chen JJ, Lin SC, et al. Detection of cardiovascular shunts by transesophageal echocardiography in
patients with pulmonary hypertension of unexplained cause. Chest 1995; 107:8
48
ANEURYSM OF DUCTUS ARTERIOSUS
 Incidence: 8%
 MC presents in infancy
 In adults develop after:
Infective endarteritis
Surgical closure
Transcatheter coil occlusion
49
ANEURYSM OF DUCTUS ARTERIOSUS
(CONT.)
 Complications:
 Thromboembolism
 Dissection
 Rupture
 Inspiratory stridor
 Left recurrent laryngeal nerve palsy
 Pulmonary artery obstruction and death
 Regression: Due to thrombosis and organization
50
MORTALITY
 Causes of death:
CCF: MC
Rupture of:
Ductal aneurysm
Hypertensive aneurysmal pulmonary
trunk
51
MORTALITY FOR UNTREATED PDA
 Cambell M estimated natural history mortality rates
for untreated PDA:
0.42% per year from age 2-19 yrs
1-1.5% per year in 3rd decade
2-2.5% per year in 4th decade
4% per year after 4th decade
 Campbell M. Natural history of persistent ductus arteriosus. Br Heart J 1968; 30: 4–13.
52
PDA IN PRETERMS
 Heart failure in first 2-3 DOL
 Surfactant treatment: Earlier manifestation
 Reopening of the duct
 Pulmonary effects:
Pulmonary edema
Pulmonary haemorrhage
Bronchopulmonary dysplasia
 Systemic and cerebral blood flow effects
53
PDA IN PRETERMS (CONT.)
 Reopening of the duct:
 Spontaneously or following indomethacin treatment
 Study on 77 preterms with complete clinical closure of PDA
after indomethacin treatment:
Clinically significant PDA recurred in 23%
Rate of reopening was related to decreasing gestational
age:
<27 weeks: 37%
27-33 weeks; 11%
 Weiss H. Factors determining reopening of DA after successful clinical closure with indomethacin. J Pediatr
995;127:466
54
PDA IN PRETERMS (CONT.)
 Pulmonary haemorrhage:
Increased pulmonary blood flow
126 babies born <30 weeks gestation
12 had pulmonary haemorrhage
Greater median PDA diameter ( 2 vs 0.5mm)
Greater PBF (326vs 237 ml/kg/min)
 Kluckow M et al. Ductal stenting, Hign PBF and pulmonary haemorrhage. J Pediatr 2000;137:68

55
PDA IN PRETERMS (CONT.)
 Bronchopulmonary dysplasia:
In clinically significant PDA: Pulmonary edema
and subsequently BPD
865 VLBW neonates: PDA associated with 4.5
fold increase in BPD
 Marshall DD et al. Risk factors for CLD in the surfactant era. North Carolina Neonatologists Association.
Pediatrics. 1999;104:1345 56
PDA IN PRETERMS (CONT.)
 Long term pulmonary effects: Related to the
duration of ductal patency even when PDA is
asymptomatic
 Increased risk of intraventricular haemorrhage in
preterms with PDA
57
PDA: NATURAL HISTORY IN A
NUTSHELL
58
Perloff 5th edition
ASD
59
INCIDENCE
 941 per million live births[1]
 13% of CHD
 Birth prevalence of 1.64 per 1,000 live births[2]
1. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890–900.
2. van der Linde D et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-
analysis. J Am Coll Cardiol 2011; 58:2241
60
INCIDENCE (CONT.)
 Female predominance : 2:1 in OS ASD[1]
 OS ASD: Sporadic with multifactorial inheritance
 Incidence of recurrence of ASD with an affected parent: 10%
(3 – 16%)[2]
 Particular association with the Holt–Oram syndrome (AD)
1. Beerman LB et al., Atrial septal defect. In: Anderson RH et al., eds. Paediatric Cardiology, 2nd edn. London:
Churchill Livingstone, 2002
2. Gold RJ, Rose V, Yau Y. Severity and recurrence risk of congenital heart defects exemplified by atrial septal
defect secundum. Clin Genet 1987; 32: 148–55
61
ASD: NATURAL HISTORY
 The natural history depends on:
Size of the defect
Rt. and Lt. ventricular diastolic compliance
Pulmonary to systemic vascular resistance
62
NATURAL HISTORY (CONT.)
 Hemodynamic / anatomic abnormalities resulting from
a OS ASD includes:
Right ventricular and atrial volume overload
Pulmonary vascular obstructive disease
Tricuspid and / or pulmonary valve regurgitation
Supraventricular tachyarrythmias 63
NATURAL HISTORY (CONT.)
 Shunt direction and magnitude are variable and age dependent
 Fetal life - RV noncompliance - unidirectional right- to–left flow
at the atrial level
 Immediately after birth - RV compliance comparable to that of
LV - little net shunting through ASD
 Physiological fall in pulmonary vascular resistance  the RV
thins  compliance increases  left-to-right shunt develops
 With similarly sized ASDs, adults have larger shunts
64
NATURAL HISTORY (CONT.)
 Most infants with ASD: Asymptomatic
 CHF: Rare in 1st decade
 Heart failure/ FTT in infancy: Rule out associated
cardiac defects
 In one series of 6 infants who had OS ASD repair before 1
year of age for failure to thrive 5 had other
pulmonary and/or cardiac disorders
Andrews R et al. Atrial septal defect with failure to thrive in infancy: hidden pulmonary vascular disease?
Pediatr Cardiol 2002; 23:528
65
NATURAL HISTORY (CONT.)
 Most children and adolescents with an isolated OS
ASD are asymptomatic even in the presence of
large shunts
 Review of 481 patients with OS ASD seen b/w
1957-76, who underwent surgical correction before
age of 40:
 Defect discovered in routine exam: 202(42%)
 More than one half had symptoms of dyspnea and
fatigue
Richard H et al. ASD of secundum type in patients under 40 years of age. A review of 481
operated cases. Symptoms, signs, treatment and early results. Scand J Thorac Cardiovasc Surg
1979;13:123
66
NATURAL HISTORY (CONT.)
 Symptoms, heart size, RVH, PA pressures, systemic
desaturation, and atrial arrhythmias increased
progressively with age[1]
 Only 4% of those over 40 years of age denied
symptoms[2]
1. Hamilton WT et al. Atrial septal defect secundum: clinical profile and physiologic correlates. In: Roberts WC, ed.
Congenital Heart Disease in Adults. Philadelphia: FA Davis, 1979: 267–81.
2. Borow KM, Karp R.Atrial septal defect. Lessons from the past, directions for the future. N Engl J Med 1990;
323: 1698–700.
67
SPONTANEOUS CLOSURE
 Spontaneous closure most likely in:
 ASDs < 7-8mm
 Younger age at diagnosis
 A review of 101 infants : mean age at diagnosis 26 days, average
follow up of 9 months:
 Spontaneous closure in all 32 ASDs < 3mm
 87% of 3 – 5 mm ASDs
 80 % of 5 - 8 mm ASDs
 None of 4 infants with defects >8mm
 Radzik D et al., J Am Coll Cardiol, 1993 68
SPONTANEOUS CLOSURE (CONT.)
Cross sectional echocardiograms on 102 consecutive neonates.
Atrial openings were evident in:
24 infants (24%): < 1 week
13 (13%): >1 week
7 (7%): > 1 month
5 (5%): > 6 months
2 (2%): > 1 year
Fukazawa M et al., Atrial septal defects in neonates with reference to spontaneous closure. Am
Heart J 1988; 116: 123–7.
69
SPONTANEOUS CLOSURE (CONT.)
 A follow up of 84 children for 4 years showed a spontaneous
closure or decreased size in:
 89% with a 4 mm ASD
 79% with 5-6mm defect
 7% with defect >6mm
 Even infants with CHF can have spontaneous reduction in the size
of ASD years after diagnosis
 Occasionally spontaneous closure can occur as late as 16 years
 Helgason H et al., pediatr cardiol, 1999 70
MECHANISMS OF SPONTANEOUS
CLOSURE OF ASD
Fusion of valve-like openings in the oval fossa:
predominant mechanism[1]
Atrial septal aneurysm: Spontaneous closure[2]
 1. Fukazawa M et al., Atrial septal defects in neonates with reference to spontaneous closure. Am Heart J
1988; 116: 123–7.
2. Brand A et al., Natural course of atrial septal aneurysm in children and the potential for spontaneous closure of
associated septal defect. Am J Cardiol 1989; 64: 996–1001. 71
ENLARGEMENT IN SIZE OF ASD
 Series of 104 patients (average age 4.5 years at diagnosis)
with isolated ASD >3 mm in size ; follow up – 3 yrs
Spontaneous closure -- in only 4 patients
ASD diameter increased in 65 %
30 % of patients had a >50 % increase in diameter
12 % had an increase to >20 mm
The only independent factor associated with growth was
the initial size of the ASD
McMahon CJ, Feltes TF, Fraley JK, et al. Natural history of growth of secundum atrial septal defects and
implications for transcatheter closure. Heart 2002; 87:256
72
SMALL ASD
Outcomes of 30 infants with an ASD considered too small for surgical
closure
 Mean age at diagnosis: 1.3 years
 Mean follow-up duration: 11.5 years
 17/30: Spontaneous closure (Mean age – 8.4 yrs)
 7/30: Asymptomatic (Average – 14 yrs) – Defect 1–6 mm
 6/30:
 Increase in size of the defect
 Secondary clinical and hemodynamic consequences
 Required intervention
Brassard M, Fouron JC, van Doesburg NH, Mercier LA, De Guise P. Outcome of children with atrial septal
defect considered too small for surgical closure. Am J Cardiol 1999; 83: 1552–5.
73
NATURAL HISTORY IN ADULTS
 Four common clinical presentation of ASD in adults:
Progressive shortness of breath with exertion
Pulmonary vascular obstructive disease
Atrial arrhythmia
Stroke or other systemic ischemic event 74
PROGRESSIVE SHORTNESS OF
BREATH
 Initial symptoms associated with an ASD may be mild and
ignored by the patient
 In a series of 32 patients diagnosed by incidental findings
on physical examination, chest x-ray, or echocardiography
who were thought to be asymptomatic, exercise
tolerance improved after closure of the ASD
Giardini A et al. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal
defect closure in asymptomatic adults. J Am Coll Cardiol 2004; 43:1886 75
ATRIAL ARRHYTHMIAS
 Part of the late natural history of ASD
 May be the first presenting sign:
13% in > 40 years
 52% in >60 years of age[1]
 Associated with morbidity and mortality especially in the older
adult patient
 Associated with the onset of CHF and systemic embolization
(stroke)
 1. St John Sutton MG et al., circulation 1981
76
ATRIAL ARRHYTHMIAS (CONT.)
 Higher pulmonary arterial pressures and a worse NYHA functional
class[1]
 Prevention of atrial arrhythmia is one of the reasons for repairing
ASD in young asymptomatic patients
 Development of AF post intervention may depend on the patient’s
age at intervention and may occur despite surgery in pts >25 years
of age[2]
 1. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal
defects in adults. N Engl J Med 1999; 340: 839–46.
2. Murphy JG et al., N Engl J Med 1990
77
ATRIAL FIBRILLATION
 In three series with a total of over 600 patients, atrial
fibrillation or atrial flutter was present in 20 %
 In a report of 211 adults, atrial fibrillation or atrial flutter:
18 - 40 years: Uncommon (1%)
40 – 60 years: 15%
>60 years : 61%
Berger F, Vogel M, Kramer A, et al. Incidence of atrial flutter/fibrillation in adults with atrial septal defect
before and after surgery. Ann Thorac Surg 1999; 68:75 78
ATRIAL FIBRILLATION (CONT.)
 Multifactorial nature of atrial fibrillation in ASD:
 Longstanding volume loading
 Pulmonary hypertension
 Ventricular dysfunction
 Atrioventricular valve regurgitation
 Increase atrial pre- and afterload
 Increase the degree of atrial myocardial stretch
 Prolongs atrial refractoriness in a heterogeneous manner
 Vulnerable to the induction of fibrillation
79
ATRIAL FIBRILLATION (CONT.)
 Predisposing conditions
Age (with a RR of 1.9 per decade of age)
LA dimension (RR 2.8 for each 10 mm increase)
MR (RR 3.0 for each degree of MR)
TR (RR 1.9 for each degree of TR)
Oliver JM, Gallego P, Gonzalez A et al. Predisposing conditions for atrial fibrillation in atrial septal
defect with and without operative closure. Am J Cardiol 2002; 89: 39–43.
80
PULMONARY VASCULAR OBSTRUCTION
 Uncommon in ASD
 Incidence: 5-10% of untreated ASDs
 Predominantly in females
 Sinus venosus ASDs have higher PA pressures and
resistances than patients with OS ASDs
Vogel M et al. Heart. 1999
81
PULMONARY VASCULAR OBSTRUCTION
(CONT.)
 169 patients with ASD:
 Pulmonary hypertension:
Sinus venosus defect: 26 %
Isolated secundum ASD: 9 %
 Elevated pulmonary vascular resistance in:
Sinus venosus defect: 16 %
Isolated secundum ASD: 4 %
Vogel M, Berger F, Kramer A, et al. Incidence of secondary pulmonary hypertension in adults with atrial
septal or sinus venosus defects. Heart 1999; 82:30
82
PULMONARY VASCULAR
OBSTRUCTION (CONT.)
83
Cherian et al. 709 patients
isolated ASD:
Used a PVR> 5Woods U as
criteria:
 12% of those <10y
 10% of those b/w 11-20y
 17% of those b/w 21-30 y
 19% of those b/w 31-40y
 11% of those >40y
Eisenmenger in:
 7% in 1st decade
 8% in 2nd decade
 10% in 3rd decade
 11% in 4th decade and
beyond
Development of pulmonary
vascular disease was
independent of age
Cherian G et al. Am Heart J.1983.
PULMONARY VASCULAR OBSTRUCTION
(CONT.)
 Eisenmenger syndrome in ASD occurs predominantly in
females
 Brickner Me at. Al. Congenital Heart Disease in Adults. N Engl J Med.2000.
84
PARADOXICAL EMBOLISATION
 Series of 103 patients (mean age 52 years) with presumed
paradoxical embolism:
PFO was present in 81
ASD in 12
Both a PFO and ASD in 10
Khositseth A et al. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale
in patients with presumed paradoxical embolism. Mayo Clin Proc 2004; 79:35
85
MVP/MR IN ASD
 MR may complicate the late course of an unrepaired OS ASD
 The morphology responsible for MR:
Prolapsing MV
Isolated cleft of the anterior mitral leaflet
 Myxomatous abnormality of the MV: 25% OS ASDs
 Mitral valve prolapse is present in up to 70 % of patients with OS
ASD
 Related to a change in the left ventricular geometry associated
with right ventricular volume overload
 Balakrishnan KG et al. Structural basis of MV dysfunction associate with OS ASDs. Cardiology. 1993;82:409-
14
86
LV DYSFUNCTION
 Uncommon
 Can occur after many years in patients with an
uncomplicated ASD
 More subtle evidence of LV dysfunction is a frequent
finding
 In a study of 12 adults with OS ASD, mean CI was
significantly reduced (3.6 vs 4.5L/min/m2)
 Papio Kaet al. Abnormalities of LV function and geometry in adults with ASD. Ventriculographic,
haemodynamic and echocardiographic studies. Am J Cardiol;1975;36:302.
87
LV DYSFUNCTION (CONT.)
 Cause: Unclear
 ?? Associated intrinsic LV abnormality
 Currently thought that reversible mechanical factors operating
primarily on diastolic function are of primary importance
 Ferlinz J. LV function in ASD: are IV interactions still too complex to permit definitive analysis? J Am Coll
Catdiol 1988;12:1237
88
LV DYSFUNCTION (CONT.)
 In an echocardiographic study of 34 children (mean age 9
years) undergoing percutaneous device closure of an
ASD:
LVEDV was diminished prior to the procedure as a
result of leftward IVS shift
 After ASD closure:
Septal shift resolved  LVEDV increased significantly
Increase in EF (from 54.9 to 62.1 %)
 Walker RE et al. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am
J Cardiol 2004; 93:1374
89
PREGNANCY & ASD
 MC Congenital cardiac lesion in pregnant women[1]
 Uncomplicated ASD; Tolerated well[2]
 Haemorrhage during delivery Inc SVR, dec
venous return Inc in Lt to Rt shunt
 ASD with pulmonary vascular disease:
 High risk of maternal/ fetal mortality
 Pregnancy to be avoided
 1. Zuber M et al. Outcome of pregnancy in women with congenital shunt lesion
 2. McFaul PB et al. Pregnancy complicated by maternal heart disease. A review of 519 women. Br J
Obstet Gynaecol 1988;95:861 90
MORTALITY
 25% OS ASD died just before their 27th year
 50% by their 36th year
 75% by 50th year
 90% by 60th year
 Mean age at death; 37.5 yrs
 Cambell M. Natural history of ASD. Br Heart J. 1970;32:820-6
91
SURVIVAL RATE
 The survival rate of children with ASD is excellent
 United Kingdom Northern Congenital Abnormality survey
of children born between 1985 and 2003 showed:
20-year estimated survival rate of 96.3 for children
diagnosed with ASD

Tennant PW, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital
anomalies: a population-based study. Lancet 2010; 375:649
92
POST INTERVENTION COMPLICATIONS AND
THEIR FOLLOWUP
 Postpericardiotomy syndrome with tamponade
 Evaluation with ECHO
 Annual clinical follow-up if ASD was repaired as an adult
and the following conditions persist or develop:
 PAH
 Atrial arrhythmias
 RV or LV dysfunction
 Coexisting valvular or other cardiac lesions 93
POST INTERVENTION COMPLICATIONS
AND THEIR FOLLOWUP
 Evaluation for possible device migration, erosion, or
other complications - 3 months to 1 year after device
closure and periodically thereafter
 Device erosion (chest pain or syncope) should warrant
urgent evaluation
94
ASD: NATURAL HISTORY IN A
NUTSHELL
95
Perloff 5th edition
THANKS
96

More Related Content

PPTX
Av canal defect
PPT
Tof physiology
PPTX
Dorv thab
PPTX
Complete transposition of great arteries
PPTX
Vsd device closure
PDF
Transposition of the great arteries(TGA)
PPTX
Transcatheter therapies for congenital heart disease
PPTX
ADULT CONGENITAL HEART DISEASE GUIDELINES - INTRODUCTION
Av canal defect
Tof physiology
Dorv thab
Complete transposition of great arteries
Vsd device closure
Transposition of the great arteries(TGA)
Transcatheter therapies for congenital heart disease
ADULT CONGENITAL HEART DISEASE GUIDELINES - INTRODUCTION

What's hot (20)

PPTX
Low flow low gradient aortic stenosis
PPTX
PPTX
Bicuspid aortic valve
PPTX
Mitral valve scoring before BMV
PPTX
Role of cinefluoroscopy in prosthetic valve disease
PPTX
Echocardiographic Evaluation of Hypertrophic Cardiomyopathy
PPTX
PPTX
TAVI - Transcatheter Aortic Valve Implantation
PPTX
Hemodyanmic features of Constrictive pericarditis and Restrictive cardiomyopathy
PPTX
Localization of WPW( accessory Pathway) by surface ECG
PPTX
PRINCIPLES AND PRACTICES OF RIGHT HEART CATHETERIZATION IN CHILDREN
PPTX
Echo Mitral Stenosis
PPTX
Chronic total occlusion (CTO)
PPTX
ECG LOCALISATION OF CULPRIT ARTERY IN STEMI
PPTX
Tte and tee assessment for asd closure 2
PPTX
Cardiac dyssynchrony ppt by dr awadhesh
PPTX
FRACTIONAL FLOW RESERVE
PPT
Assessment of shunt by cardiac catheterization
PPTX
Strain and strain rate
Low flow low gradient aortic stenosis
Bicuspid aortic valve
Mitral valve scoring before BMV
Role of cinefluoroscopy in prosthetic valve disease
Echocardiographic Evaluation of Hypertrophic Cardiomyopathy
TAVI - Transcatheter Aortic Valve Implantation
Hemodyanmic features of Constrictive pericarditis and Restrictive cardiomyopathy
Localization of WPW( accessory Pathway) by surface ECG
PRINCIPLES AND PRACTICES OF RIGHT HEART CATHETERIZATION IN CHILDREN
Echo Mitral Stenosis
Chronic total occlusion (CTO)
ECG LOCALISATION OF CULPRIT ARTERY IN STEMI
Tte and tee assessment for asd closure 2
Cardiac dyssynchrony ppt by dr awadhesh
FRACTIONAL FLOW RESERVE
Assessment of shunt by cardiac catheterization
Strain and strain rate
Ad

Similar to NATURAL HISTORY OF ASD, VSD, PDA (20)

PPT
Natural history of common congenital heart diseases
PPTX
Ventricular septal defects
PPTX
PPTX
Congenital heart disease - ASD and VSD .
PDF
Left-Right Shunt Natural history & Principles of Management
PPTX
VSD : Dr. Akif Baig
PDF
V s d may 2021
PPTX
VSD_Pediatric_Cardiology and paeds residents
PPT
VENTRICULAR SEPTAL DEFECT
PPTX
Ventricular Septal defects Echocardiography
PPTX
acyanotic heart disease in adults reviewpptx
PPTX
Ventricular septal defect VSD . Firas Aljanadi-Oct 2019
PPTX
Ventricular Septal Defect
PPTX
Ventricular septal defect VSD
PPTX
Acyanotic chd
PPTX
Congenital Heart Diseases BDS 2024.pptx
PPTX
MANAGEMENT OF VSD
PPTX
Ventricular septal defect, congenital heart disease
PPT
Congenital heart diseases
Natural history of common congenital heart diseases
Ventricular septal defects
Congenital heart disease - ASD and VSD .
Left-Right Shunt Natural history & Principles of Management
VSD : Dr. Akif Baig
V s d may 2021
VSD_Pediatric_Cardiology and paeds residents
VENTRICULAR SEPTAL DEFECT
Ventricular Septal defects Echocardiography
acyanotic heart disease in adults reviewpptx
Ventricular septal defect VSD . Firas Aljanadi-Oct 2019
Ventricular Septal Defect
Ventricular septal defect VSD
Acyanotic chd
Congenital Heart Diseases BDS 2024.pptx
MANAGEMENT OF VSD
Ventricular septal defect, congenital heart disease
Congenital heart diseases
Ad

More from Dr. Murtaza Kamal MRCPCH,MD,DNB,DrNB Ped Cardiology (20)

PPTX
PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
PPTX
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
PPTX
PEDIATRIC CARDIOLOGY CASE SCENARIOS
PPTX
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
PPTX
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
PPTX
WHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
PPTX
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
PPTX
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
PPTX
PEDAITRIC OBESITY AND HYPERLIPEDEMIA
PPTX
Micronutrient deficiency In Children
PPTX
DYSBIOSIS IN CHILDREN BORN BY CAESAREAN SECTION
PPTX
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
PPTX
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
PPTX
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
PPTX
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
PPTX
Cath meet 25020202 (TGA, VSD, PS FOR PA PRESSURES)
PPTX
Cath meet 03022020 (VSD PAH FOR REVERSIBILITY, PVR)
PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
PEDIATRIC CARDIOLOGY CASE SCENARIOS
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
WHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
PEDAITRIC OBESITY AND HYPERLIPEDEMIA
Micronutrient deficiency In Children
DYSBIOSIS IN CHILDREN BORN BY CAESAREAN SECTION
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
Cath meet 25020202 (TGA, VSD, PS FOR PA PRESSURES)
Cath meet 03022020 (VSD PAH FOR REVERSIBILITY, PVR)

Recently uploaded (20)

PPTX
Neuropathic pain.ppt treatment managment
PPTX
ACID BASE management, base deficit correction
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPTX
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
PPTX
Imaging of parasitic D. Case Discussions.pptx
PPTX
Clinical approach and Radiotherapy principles.pptx
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPTX
neonatal infection(7392992y282939y5.pptx
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPTX
Transforming Regulatory Affairs with ChatGPT-5.pptx
PPTX
Acid Base Disorders educational power point.pptx
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
anal canal anatomy with illustrations...
PPTX
Note on Abortion.pptx for the student note
Neuropathic pain.ppt treatment managment
ACID BASE management, base deficit correction
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
Imaging of parasitic D. Case Discussions.pptx
Clinical approach and Radiotherapy principles.pptx
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
OPIOID ANALGESICS AND THEIR IMPLICATIONS
neonatal infection(7392992y282939y5.pptx
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
Transforming Regulatory Affairs with ChatGPT-5.pptx
Acid Base Disorders educational power point.pptx
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
Copy of OB - Exam #2 Study Guide. pdf
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
anal canal anatomy with illustrations...
Note on Abortion.pptx for the student note

NATURAL HISTORY OF ASD, VSD, PDA

  • 1. NATURAL HISTORY OF ASD/ VSD/ PDA Dr. Murtaza Kamal MBBS, MD, DNB DNB SS RESIDENT (PEDIATRIC CARDIOLOGY) murtaza.vmmc@gmail.com DOP:031017 1
  • 3. INCIDENCE  Most common CHD  Isolated VSD: 20 – 30% of all CHD  Echo studies: 5-50/1,000 newborns [1]  No sex preference 1. Ooshima A et al. Cardiology 1995;86:402-406. 3
  • 4. CLASSIFICATION OF VSD Soto et al classification of VSD  Perimembranous (membranous/ infracristal ): 70-80%  Muscular: 5-20%  Central- mid muscular  Apical  Marginal- along RV septal junction  Swiss cheese septum – multiple defects  Inlet/ AV canal type: 5-8%  Supracrital (Conal/ infundibular/subpulmonary/doubly committed subarterial): 5-7% Benigno soto et al. Br HeartJ 1980; 43: 332-343 4
  • 5. HAEMODYNAMIC CLASSIFICATION 5 Perloff’s Clinical Recognition of CHD 6th Edition
  • 6. FACTORS INFLUENCING OUTCOMES & NATURAL HISTORY OF VSD Position & Size Number of defects Anatomic structures in the vicinity of the defect Association of other malformation Age at which the defect is recognized Sex of the patient 6
  • 7. NATURAL HISTORY: VSD  Cardiac failure  Spontaneous diminution in size or closure  Right or Left ventricular outflow tract obstruction  Aortic regurgitation  Pulmonary vascular obstructive disease  Infective endocarditis 7
  • 9. CARDIAC FAILURE (CONT.) Rare in small VSD as size limits the L-R shunt  In large VSD the relative resistances of the systemic and pulmonary circulations regulate flow  Shunt occurs mainly in systole  Shunt directly to PA  Enlargement of LA, LV, PA 9
  • 10. CARDIAC FAILURE (CONT.)  Moderate sized VSD: Symptoms by 3- 6 months  Large VSD: CHF in first few weeks  Risk for recurrent pulmonary infection high, failure to thrive  If survives without therapy: Pulmonary vascular disease develops in the first few years of life  Rudolph AM, et al.Pediatrics 1965;36:763-772 10
  • 11. 2. SPONTANEOUS DIMINUTION IN SIZE  Occurs in both: Perimembranous+ muscular  Closure documented in fetus and adults  VSD diagnosed in the fetus: 46% (in utero closed), 23.1% (closed in 1st YOL), 30.8% (remained patent)  15.8% of defects <3mm, 71.4% of defects >3mm: remained patent at 1YOL  None of the malaligned defects closed  69% of the perimembranous defects and 60% of muscular trabecular defects closed spontaneously 11 *Nir A et al.Pediatr Cardiol 1990; 11: 208–10
  • 12. SPONTANEOUS DIMINUTION IN SIZE (CONT.) 12 More common in <10 years of age 75% of small VSDs and 83% of muscular defects close spontaneously by 10 years of age[1] 1. Alpert BS et al., Spontaneous closure of small ventricular septal defects: ten-year follow-up. Pediatrics 1979; 63: 204–6
  • 13. SPONTANEOUS DIMINUTION IN SIZE (CONT.) .  Spontaneous closure decreases substantially after 1 year of age  Female predominance  1. Moe DG, Guntheroth WG. Spontaneous closure of uncomplicated ventricular septal defect. Am J Cardiol 1987; 60: 674–8.  2. Farina MA et al . J Pediatr 1978; 93: 1065–6. 13
  • 14. SPONTANEOUS DIMINUTION IN SIZE (CONT.)  During adolescence -- diminution in size of the defect in > 20%[1]  VSD can even close in the adults: [2] Spontaneous closure  In 10% of 188 adults 17 to 45 years Followed for a mean of 13 years  1. Onat T, Ahunbay G, Batmaz G, Celebi A.The natural course of isolated ventricular septal defect during adolescence. Pediatr Cardiol 1998; 19: 230–4. 2. Neumayer U, Stone S, Somerville J. Small ventricular septal defects in adults. Eur Heart J 1998 14
  • 15. SPONTANEOUS DIMINUTION IN SIZE (CONT.)  Malaligned VSD rarely undergoes spontaneous closure or diminution in size Only in 4% of patients All of the defects were initially < 4 mm in diameter Tomita H, Arakaki Y,Yagihara T, Echigo S. Incidence of spontaneous closure of outlet ventricular septal defect. Jpn Circ J 2001; 65: 364–6. 15
  • 16. MECHANISMS OF SPONTANEOUS CLOSURE OF VSD 16 A. Closure of a perimembranous defect by adhesion of the tricuspid leaflets to the defect margin. B. Closure of a small muscular defect by a fibrous tissue plug. C. Closure of a muscular defect by hypertrophied muscle bundles in the right ventricle D. Closure of a defect in subaortic location by adhesion of the prolapsed aortic valve cusp E. Aneurysmal transformation of the membranous septum
  • 17. 3. RVOT OBSTRUCTION  Incidence: 3-7%  Mechanism:  Hypertrophy of malaligned infundibular septum  Hypertrophy of right ventricular muscle bundles  Prolapsing aortic valve leaflet High incidence in:  Rt sided aortic arch  Horizontal RVOT Varghese PJ et al . Br Heart J 1970; 32: 537–46 Tyrrell MJ et al. Circulation 1970; 41 & 42(Suppl. III): 113 17
  • 18. AORTIC VALVE PROLAPSE  VSD with direct contact with aortic valve are most prone to develop AVP: All perimembranous defects All doubly committed juxta arterial defects Most of muscular outlet defects Prevalence of AOP (2-7%) Rare before age of 2 years Nadas AS et al . Circulation 1977; 56(No.2, Suppl. I): 1–87. 18
  • 19. AORTIC VALVE PROLAPSE (CONT.)  RCC (60-70%), NCC (10-15%), Both (10-20%), LCC (extremely rare)  NCC prolapses in perimembranous type VSD  AR may be due to incompetent bicuspid valve  Prolapsed valve may perforate rarely 19
  • 20. AORTIC VALVE PROLAPSE (CONT.)  Aortic regurgitation: 10%  Increases with age  Infundibular VSD vs membranous VSD – RR 2.5  AR is progressive , so early surgical intervention needed  Momma K, Toyama K, Takao A, et al. Natural history of subarterial infundibular ventricular septal defect. Am Heart J 1984; 108:1312 20
  • 21. AORTIC VALVE PROLAPSE (CONT.) 21
  • 22. AORTIC VALVE PROLAPSE (CONT.) 22 Parasternal long-axis echocardiogram view showing supracristal ventricular septal defect (arrow) with buckling and prolapse of the right coronary cusp of the aortic valve.
  • 23. VSD WITH AI- INDIAN SCENARIO  Sample size: 362, 37(10.2%) had AI  Mean age: 13.4 y (2-45yrs), M:F::5:1  31(84%): Infracristal; 6(16%): Supracristal VSDs  In infracristal VSD: RCC prolapse:14(48%); NCC: 12(41%); Both: 3(11%)  In supracristal VSD: RCC prolapse: 5(83%); NCC prolapse: 1(17%)  2 patients, AR due to bicuspid aortic valve  No relationship- severity of AR & location of VSD  Somanath HS et al. Indian Heart J. 1990 Mar-Apr;42(2):113-6. 23
  • 24. INTERVENTION IN VSD WITH AVP  Indicated for both perimembranous and subarterial VSDs when more than trivial AI  Subarterial VSDs >5mm: Closed regardless of AVP  Restrictive perimembranous VSD with AVP but without AI, surgery indications less clear: Regular follow up Surgery indicated only if AI develops  1. Elgamal MA et al . Ann Thorac Surg 68:1350-1355, 1999 2. Lun K et al. Am J Cardiol 87:1266-1270, 2001 3. Gabriel HM et al. J Am Coll Cardiol 39:1066-1071, 2002 24
  • 25. LVOT OBSTRUCTION  Usually above the defect and occasionally below  May be evident from immediate post natal period  Progression of the pre-existing lesion or can be acquired  Obstruction is either muscular of fibromuscular Starnes SL et al. Thorac Cardiovasc Surg 2001; 122: 518–23., Liu SP et al. Endothelion 1994; 2: 11–33 25
  • 26. 4. PULMONARY VASCULAR OBSTRUCTION  Incidence: 5-22%[1]  Rare in small and moderate sized VSDs  Mechanism: Excessive pulmonary blood flow Vessel injury Thick adventitia, medial hypertrophy, intimal injury[2]  Down syndrome babies develop PAH early  No sex predilection  Infants with VSD and increased pulmonary arterial pressure- repair between 3-12 months  1. Keith JD et al. Heart Disease in Infancy and Childhood. 1978: 320–79  2. Wilkinson JL.. Ped Cardiovascular Med. 2000;289–09  3. DuShane JW, et al.The Child with CHD after Surgery. Futura Publ.1976 26
  • 27. 5. INFECTIVE ENDOCARDITIS  18.7 per 10,000 person years in non operated cases  Operated VSDs: 7.3 per 10,000 person-years  Higher in small defect and lower during childhood  Age >20years and male sex are other risk factors Gersony WM et al.Circulation 1993; 87(Suppl. I):I-121–I-126 27
  • 28. INFECTIVE ENDOCARDITIS (CONT.)  TEE: Diagnostic procedure of choice  Membranous VSD: Vegetation on the tricuspid valve  Infundibular defects: Aortic or pulmonary valve vegetation  ACC/AHA : No antibiotic prophylaxis for the acyanotic uncomplicated VSD with no prior history of endocarditis  Patients with a proven episode of endocarditis: Increased risk of recurrent infections, so surgical closure may be recommendedtion so surgical closure may be recommended 28
  • 29. ENDOCARDITIS PROPHYLAXIS  The 2007 guidelines of the AHA recommend no antibiotic prophylaxis in children with an isolated VSD except :  During the first six months after the repair with prosthetic material or device  Repaired VSD with a residual defect at the site or adjacent to the site of a prosthetic device  Prophylactic antibiotics is recommended for dental and respiratory tract procedures 29
  • 30. 6. ARRHYTHMIAS  Presenting signs of VSD in adults  Ventricular tachycardias : 5.7 %  Sudden death: 4.0 %  Age and pulmonary artery pressure: Best predictors for ventricular arrhythmias  Assess for candidacy for VSD repair in all adults with VSD and cardiac arrhythmias 1. Wolfe RR et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect. Results of 24-hour ECG monitoring. Circulation 1993; 87:I89. 30
  • 31. ARRHYTHMIAS (CONT.)  VSD with Eisenmenger syndrome:  VT: 19%  Hypertrophied RV : Ideal for ventricular arrhythmias  Atrial fibrillation:  Prevalent in adult VSD  Risk factors: Increasing age LV dysfunction Elevated PA pressure  Kidd L et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation 1993; 87:I38 31
  • 32. CAUSES OF IMPROVEMENT IN SYMPTOMS OF VSD  Closing defect: Soft S2  Increasing PVR: Increased RV pulsations, parasternal heave, S2 loud  Infundibular hypertrophy & resulting decreased L to R shunt: S2 decreases in intensity ,crescendo- decrescendo systolic murmur in the ULSB  Cyanosis (shunt reversal ) 32
  • 33. COURSE OF A SMALL VSD 33
  • 34. PREGNANCY AND VSD  Mother: Cardiac complications rare  No events of arrhythmias, heart failure  Cardiovascular events (MI, stroke, CV mortality): 1%  Fetus  Preterm delivery :11.7%  Fetal mortality : 1.3%  Recurrent congenital heart disease of any type : 2.7% Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49:2303 34
  • 35. NATURAL HISTORY OF CHD STUDIES 35
  • 36. VSD: NATURAL HISTORY IN A NUTSHELL 36 Perloff 5th edition
  • 38. INTRODUCTION  Functional closure in term infants within 10–15 h  <30 weeks gestation : PDA persists D4OL in 65 %  Anatomical closure is usually complete: 3months  PDA-Continued patency in infants older than 3 months  Incidence : 5.3–11.0% (median 7.1%) of all congenital cardiac lesions  Casseles DE. The ductus arteriosus. 1973:91 38
  • 39. INTRODUCTION (CONT.)  2.9 per 10,000 live births (population-based study of 400,000 term infants)[1] Isolated PDA among term infants - 0.03 to 0.08 %[2]  In very low birth weight infants (< 1500 g) - 30 %[3] 1. Reller MD et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008; 153:807 2. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39:1890 3. Lemons JA et al. Very low birth weight outcomes of the NICHD Neona 39
  • 40. INTRODUCTION (CONT.) Incidence of silent ductus not known (0.1–0.2% of the population may be affected)  Incidence of re-patency of the arterial duct after initial closure: 0.9%[1]  Incidence of isolated PDA in term infants: 1 in 2,000[2]  Female predominance - 3:1 (except in congenital rubella)[3]  1. Raaijmaakers B etal., Difficulties generated by the small, permanently patent, arterial duct. Cardiol Young 1999; 9: 392–5.  2. Carlgren LE et al. Br Heart J. 1959;21:40 –50.  3. Zetterquist P et al. University of Uppsala, Sweden 1972 40
  • 41. INTRODUCTION (CONT.)  High incidence in: Maternal rubella Preterms, LBW babies: <1750g: 50% <1200g: 80%[1]  Teratogens (18-60 days of gestation): Alcohol/ amphitamines/ phenytoin  Siblings have increased risk (2-4%)  1. Gibson S et al. Am J Dis Child. 1952;83:117–119. 41
  • 42. NATURAL HISTORY  Depends on: Size and magnitude of shunt Status of pulmonary vasculature 42
  • 43. SIZE OF PDA SMALL MODERATE LARGE Mostly asymptomatic LV volume overload LV volume overload and cardiac failure at 3 months of age Increased risk of endarteritis Rarely rhythm disturbances like atrial fibrillation Increased pulmonary resistance Eisenmenger’s syndrome occurs by 1st decade 43
  • 44. NATURAL HISTORY  Congestive heart failure  Infective endarteritis  Pulmonary vascular disease  Aneurysmal formation  Thromboembolism  Calcification 44
  • 45. CONGESTIVE HEART FAILURE  Clinical course is similar as VSD  Depends on size, magnitude of shunt & the status of the pulmonary vasculature  CHF develops in infancy or during adult life  Heart failure in infancy usually occurs before 3 months of age  Commonest cause of death  Initially lt heart failure, later right heart failure 45
  • 46. INFECTIVE ENDARTERITIS  Incidence: 1% per year  Decreased dramatically since the early natural history studies before the era of routine surgical closure and antibiotic usage  Vegetations usually occur on PA end, embolic events usually of the lungs rather than systemic circulation  Perloff 5TH edition 46
  • 47. PULMONARY VASCULAR DISEASE  Large PDA if defect not repaired  No definite data on incidence  Differential cyanosis  Non restrictive PDA, Eisenmenger’s develops by 1st decade  Eisenmenger patients do no tolerate PDA closure 47
  • 48. PULMONARY VASCULAR DISEASE (CONT.)  PDA: Relatively common cause of PAH of unknown cause in adolescents and adults  In one series of 24 patients, 16 had a left-to-right shunt with PAH of unexplained cause: ASD in 8 PDA in 6 VSD in 2 In this series these lesions were best detected by transesophageal echocardiography Chen WJ, Chen JJ, Lin SC, et al. Detection of cardiovascular shunts by transesophageal echocardiography in patients with pulmonary hypertension of unexplained cause. Chest 1995; 107:8 48
  • 49. ANEURYSM OF DUCTUS ARTERIOSUS  Incidence: 8%  MC presents in infancy  In adults develop after: Infective endarteritis Surgical closure Transcatheter coil occlusion 49
  • 50. ANEURYSM OF DUCTUS ARTERIOSUS (CONT.)  Complications:  Thromboembolism  Dissection  Rupture  Inspiratory stridor  Left recurrent laryngeal nerve palsy  Pulmonary artery obstruction and death  Regression: Due to thrombosis and organization 50
  • 51. MORTALITY  Causes of death: CCF: MC Rupture of: Ductal aneurysm Hypertensive aneurysmal pulmonary trunk 51
  • 52. MORTALITY FOR UNTREATED PDA  Cambell M estimated natural history mortality rates for untreated PDA: 0.42% per year from age 2-19 yrs 1-1.5% per year in 3rd decade 2-2.5% per year in 4th decade 4% per year after 4th decade  Campbell M. Natural history of persistent ductus arteriosus. Br Heart J 1968; 30: 4–13. 52
  • 53. PDA IN PRETERMS  Heart failure in first 2-3 DOL  Surfactant treatment: Earlier manifestation  Reopening of the duct  Pulmonary effects: Pulmonary edema Pulmonary haemorrhage Bronchopulmonary dysplasia  Systemic and cerebral blood flow effects 53
  • 54. PDA IN PRETERMS (CONT.)  Reopening of the duct:  Spontaneously or following indomethacin treatment  Study on 77 preterms with complete clinical closure of PDA after indomethacin treatment: Clinically significant PDA recurred in 23% Rate of reopening was related to decreasing gestational age: <27 weeks: 37% 27-33 weeks; 11%  Weiss H. Factors determining reopening of DA after successful clinical closure with indomethacin. J Pediatr 995;127:466 54
  • 55. PDA IN PRETERMS (CONT.)  Pulmonary haemorrhage: Increased pulmonary blood flow 126 babies born <30 weeks gestation 12 had pulmonary haemorrhage Greater median PDA diameter ( 2 vs 0.5mm) Greater PBF (326vs 237 ml/kg/min)  Kluckow M et al. Ductal stenting, Hign PBF and pulmonary haemorrhage. J Pediatr 2000;137:68  55
  • 56. PDA IN PRETERMS (CONT.)  Bronchopulmonary dysplasia: In clinically significant PDA: Pulmonary edema and subsequently BPD 865 VLBW neonates: PDA associated with 4.5 fold increase in BPD  Marshall DD et al. Risk factors for CLD in the surfactant era. North Carolina Neonatologists Association. Pediatrics. 1999;104:1345 56
  • 57. PDA IN PRETERMS (CONT.)  Long term pulmonary effects: Related to the duration of ductal patency even when PDA is asymptomatic  Increased risk of intraventricular haemorrhage in preterms with PDA 57
  • 58. PDA: NATURAL HISTORY IN A NUTSHELL 58 Perloff 5th edition
  • 60. INCIDENCE  941 per million live births[1]  13% of CHD  Birth prevalence of 1.64 per 1,000 live births[2] 1. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890–900. 2. van der Linde D et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta- analysis. J Am Coll Cardiol 2011; 58:2241 60
  • 61. INCIDENCE (CONT.)  Female predominance : 2:1 in OS ASD[1]  OS ASD: Sporadic with multifactorial inheritance  Incidence of recurrence of ASD with an affected parent: 10% (3 – 16%)[2]  Particular association with the Holt–Oram syndrome (AD) 1. Beerman LB et al., Atrial septal defect. In: Anderson RH et al., eds. Paediatric Cardiology, 2nd edn. London: Churchill Livingstone, 2002 2. Gold RJ, Rose V, Yau Y. Severity and recurrence risk of congenital heart defects exemplified by atrial septal defect secundum. Clin Genet 1987; 32: 148–55 61
  • 62. ASD: NATURAL HISTORY  The natural history depends on: Size of the defect Rt. and Lt. ventricular diastolic compliance Pulmonary to systemic vascular resistance 62
  • 63. NATURAL HISTORY (CONT.)  Hemodynamic / anatomic abnormalities resulting from a OS ASD includes: Right ventricular and atrial volume overload Pulmonary vascular obstructive disease Tricuspid and / or pulmonary valve regurgitation Supraventricular tachyarrythmias 63
  • 64. NATURAL HISTORY (CONT.)  Shunt direction and magnitude are variable and age dependent  Fetal life - RV noncompliance - unidirectional right- to–left flow at the atrial level  Immediately after birth - RV compliance comparable to that of LV - little net shunting through ASD  Physiological fall in pulmonary vascular resistance  the RV thins  compliance increases  left-to-right shunt develops  With similarly sized ASDs, adults have larger shunts 64
  • 65. NATURAL HISTORY (CONT.)  Most infants with ASD: Asymptomatic  CHF: Rare in 1st decade  Heart failure/ FTT in infancy: Rule out associated cardiac defects  In one series of 6 infants who had OS ASD repair before 1 year of age for failure to thrive 5 had other pulmonary and/or cardiac disorders Andrews R et al. Atrial septal defect with failure to thrive in infancy: hidden pulmonary vascular disease? Pediatr Cardiol 2002; 23:528 65
  • 66. NATURAL HISTORY (CONT.)  Most children and adolescents with an isolated OS ASD are asymptomatic even in the presence of large shunts  Review of 481 patients with OS ASD seen b/w 1957-76, who underwent surgical correction before age of 40:  Defect discovered in routine exam: 202(42%)  More than one half had symptoms of dyspnea and fatigue Richard H et al. ASD of secundum type in patients under 40 years of age. A review of 481 operated cases. Symptoms, signs, treatment and early results. Scand J Thorac Cardiovasc Surg 1979;13:123 66
  • 67. NATURAL HISTORY (CONT.)  Symptoms, heart size, RVH, PA pressures, systemic desaturation, and atrial arrhythmias increased progressively with age[1]  Only 4% of those over 40 years of age denied symptoms[2] 1. Hamilton WT et al. Atrial septal defect secundum: clinical profile and physiologic correlates. In: Roberts WC, ed. Congenital Heart Disease in Adults. Philadelphia: FA Davis, 1979: 267–81. 2. Borow KM, Karp R.Atrial septal defect. Lessons from the past, directions for the future. N Engl J Med 1990; 323: 1698–700. 67
  • 68. SPONTANEOUS CLOSURE  Spontaneous closure most likely in:  ASDs < 7-8mm  Younger age at diagnosis  A review of 101 infants : mean age at diagnosis 26 days, average follow up of 9 months:  Spontaneous closure in all 32 ASDs < 3mm  87% of 3 – 5 mm ASDs  80 % of 5 - 8 mm ASDs  None of 4 infants with defects >8mm  Radzik D et al., J Am Coll Cardiol, 1993 68
  • 69. SPONTANEOUS CLOSURE (CONT.) Cross sectional echocardiograms on 102 consecutive neonates. Atrial openings were evident in: 24 infants (24%): < 1 week 13 (13%): >1 week 7 (7%): > 1 month 5 (5%): > 6 months 2 (2%): > 1 year Fukazawa M et al., Atrial septal defects in neonates with reference to spontaneous closure. Am Heart J 1988; 116: 123–7. 69
  • 70. SPONTANEOUS CLOSURE (CONT.)  A follow up of 84 children for 4 years showed a spontaneous closure or decreased size in:  89% with a 4 mm ASD  79% with 5-6mm defect  7% with defect >6mm  Even infants with CHF can have spontaneous reduction in the size of ASD years after diagnosis  Occasionally spontaneous closure can occur as late as 16 years  Helgason H et al., pediatr cardiol, 1999 70
  • 71. MECHANISMS OF SPONTANEOUS CLOSURE OF ASD Fusion of valve-like openings in the oval fossa: predominant mechanism[1] Atrial septal aneurysm: Spontaneous closure[2]  1. Fukazawa M et al., Atrial septal defects in neonates with reference to spontaneous closure. Am Heart J 1988; 116: 123–7. 2. Brand A et al., Natural course of atrial septal aneurysm in children and the potential for spontaneous closure of associated septal defect. Am J Cardiol 1989; 64: 996–1001. 71
  • 72. ENLARGEMENT IN SIZE OF ASD  Series of 104 patients (average age 4.5 years at diagnosis) with isolated ASD >3 mm in size ; follow up – 3 yrs Spontaneous closure -- in only 4 patients ASD diameter increased in 65 % 30 % of patients had a >50 % increase in diameter 12 % had an increase to >20 mm The only independent factor associated with growth was the initial size of the ASD McMahon CJ, Feltes TF, Fraley JK, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 2002; 87:256 72
  • 73. SMALL ASD Outcomes of 30 infants with an ASD considered too small for surgical closure  Mean age at diagnosis: 1.3 years  Mean follow-up duration: 11.5 years  17/30: Spontaneous closure (Mean age – 8.4 yrs)  7/30: Asymptomatic (Average – 14 yrs) – Defect 1–6 mm  6/30:  Increase in size of the defect  Secondary clinical and hemodynamic consequences  Required intervention Brassard M, Fouron JC, van Doesburg NH, Mercier LA, De Guise P. Outcome of children with atrial septal defect considered too small for surgical closure. Am J Cardiol 1999; 83: 1552–5. 73
  • 74. NATURAL HISTORY IN ADULTS  Four common clinical presentation of ASD in adults: Progressive shortness of breath with exertion Pulmonary vascular obstructive disease Atrial arrhythmia Stroke or other systemic ischemic event 74
  • 75. PROGRESSIVE SHORTNESS OF BREATH  Initial symptoms associated with an ASD may be mild and ignored by the patient  In a series of 32 patients diagnosed by incidental findings on physical examination, chest x-ray, or echocardiography who were thought to be asymptomatic, exercise tolerance improved after closure of the ASD Giardini A et al. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol 2004; 43:1886 75
  • 76. ATRIAL ARRHYTHMIAS  Part of the late natural history of ASD  May be the first presenting sign: 13% in > 40 years  52% in >60 years of age[1]  Associated with morbidity and mortality especially in the older adult patient  Associated with the onset of CHF and systemic embolization (stroke)  1. St John Sutton MG et al., circulation 1981 76
  • 77. ATRIAL ARRHYTHMIAS (CONT.)  Higher pulmonary arterial pressures and a worse NYHA functional class[1]  Prevention of atrial arrhythmia is one of the reasons for repairing ASD in young asymptomatic patients  Development of AF post intervention may depend on the patient’s age at intervention and may occur despite surgery in pts >25 years of age[2]  1. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999; 340: 839–46. 2. Murphy JG et al., N Engl J Med 1990 77
  • 78. ATRIAL FIBRILLATION  In three series with a total of over 600 patients, atrial fibrillation or atrial flutter was present in 20 %  In a report of 211 adults, atrial fibrillation or atrial flutter: 18 - 40 years: Uncommon (1%) 40 – 60 years: 15% >60 years : 61% Berger F, Vogel M, Kramer A, et al. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg 1999; 68:75 78
  • 79. ATRIAL FIBRILLATION (CONT.)  Multifactorial nature of atrial fibrillation in ASD:  Longstanding volume loading  Pulmonary hypertension  Ventricular dysfunction  Atrioventricular valve regurgitation  Increase atrial pre- and afterload  Increase the degree of atrial myocardial stretch  Prolongs atrial refractoriness in a heterogeneous manner  Vulnerable to the induction of fibrillation 79
  • 80. ATRIAL FIBRILLATION (CONT.)  Predisposing conditions Age (with a RR of 1.9 per decade of age) LA dimension (RR 2.8 for each 10 mm increase) MR (RR 3.0 for each degree of MR) TR (RR 1.9 for each degree of TR) Oliver JM, Gallego P, Gonzalez A et al. Predisposing conditions for atrial fibrillation in atrial septal defect with and without operative closure. Am J Cardiol 2002; 89: 39–43. 80
  • 81. PULMONARY VASCULAR OBSTRUCTION  Uncommon in ASD  Incidence: 5-10% of untreated ASDs  Predominantly in females  Sinus venosus ASDs have higher PA pressures and resistances than patients with OS ASDs Vogel M et al. Heart. 1999 81
  • 82. PULMONARY VASCULAR OBSTRUCTION (CONT.)  169 patients with ASD:  Pulmonary hypertension: Sinus venosus defect: 26 % Isolated secundum ASD: 9 %  Elevated pulmonary vascular resistance in: Sinus venosus defect: 16 % Isolated secundum ASD: 4 % Vogel M, Berger F, Kramer A, et al. Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart 1999; 82:30 82
  • 83. PULMONARY VASCULAR OBSTRUCTION (CONT.) 83 Cherian et al. 709 patients isolated ASD: Used a PVR> 5Woods U as criteria:  12% of those <10y  10% of those b/w 11-20y  17% of those b/w 21-30 y  19% of those b/w 31-40y  11% of those >40y Eisenmenger in:  7% in 1st decade  8% in 2nd decade  10% in 3rd decade  11% in 4th decade and beyond Development of pulmonary vascular disease was independent of age Cherian G et al. Am Heart J.1983.
  • 84. PULMONARY VASCULAR OBSTRUCTION (CONT.)  Eisenmenger syndrome in ASD occurs predominantly in females  Brickner Me at. Al. Congenital Heart Disease in Adults. N Engl J Med.2000. 84
  • 85. PARADOXICAL EMBOLISATION  Series of 103 patients (mean age 52 years) with presumed paradoxical embolism: PFO was present in 81 ASD in 12 Both a PFO and ASD in 10 Khositseth A et al. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc 2004; 79:35 85
  • 86. MVP/MR IN ASD  MR may complicate the late course of an unrepaired OS ASD  The morphology responsible for MR: Prolapsing MV Isolated cleft of the anterior mitral leaflet  Myxomatous abnormality of the MV: 25% OS ASDs  Mitral valve prolapse is present in up to 70 % of patients with OS ASD  Related to a change in the left ventricular geometry associated with right ventricular volume overload  Balakrishnan KG et al. Structural basis of MV dysfunction associate with OS ASDs. Cardiology. 1993;82:409- 14 86
  • 87. LV DYSFUNCTION  Uncommon  Can occur after many years in patients with an uncomplicated ASD  More subtle evidence of LV dysfunction is a frequent finding  In a study of 12 adults with OS ASD, mean CI was significantly reduced (3.6 vs 4.5L/min/m2)  Papio Kaet al. Abnormalities of LV function and geometry in adults with ASD. Ventriculographic, haemodynamic and echocardiographic studies. Am J Cardiol;1975;36:302. 87
  • 88. LV DYSFUNCTION (CONT.)  Cause: Unclear  ?? Associated intrinsic LV abnormality  Currently thought that reversible mechanical factors operating primarily on diastolic function are of primary importance  Ferlinz J. LV function in ASD: are IV interactions still too complex to permit definitive analysis? J Am Coll Catdiol 1988;12:1237 88
  • 89. LV DYSFUNCTION (CONT.)  In an echocardiographic study of 34 children (mean age 9 years) undergoing percutaneous device closure of an ASD: LVEDV was diminished prior to the procedure as a result of leftward IVS shift  After ASD closure: Septal shift resolved  LVEDV increased significantly Increase in EF (from 54.9 to 62.1 %)  Walker RE et al. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol 2004; 93:1374 89
  • 90. PREGNANCY & ASD  MC Congenital cardiac lesion in pregnant women[1]  Uncomplicated ASD; Tolerated well[2]  Haemorrhage during delivery Inc SVR, dec venous return Inc in Lt to Rt shunt  ASD with pulmonary vascular disease:  High risk of maternal/ fetal mortality  Pregnancy to be avoided  1. Zuber M et al. Outcome of pregnancy in women with congenital shunt lesion  2. McFaul PB et al. Pregnancy complicated by maternal heart disease. A review of 519 women. Br J Obstet Gynaecol 1988;95:861 90
  • 91. MORTALITY  25% OS ASD died just before their 27th year  50% by their 36th year  75% by 50th year  90% by 60th year  Mean age at death; 37.5 yrs  Cambell M. Natural history of ASD. Br Heart J. 1970;32:820-6 91
  • 92. SURVIVAL RATE  The survival rate of children with ASD is excellent  United Kingdom Northern Congenital Abnormality survey of children born between 1985 and 2003 showed: 20-year estimated survival rate of 96.3 for children diagnosed with ASD  Tennant PW, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital anomalies: a population-based study. Lancet 2010; 375:649 92
  • 93. POST INTERVENTION COMPLICATIONS AND THEIR FOLLOWUP  Postpericardiotomy syndrome with tamponade  Evaluation with ECHO  Annual clinical follow-up if ASD was repaired as an adult and the following conditions persist or develop:  PAH  Atrial arrhythmias  RV or LV dysfunction  Coexisting valvular or other cardiac lesions 93
  • 94. POST INTERVENTION COMPLICATIONS AND THEIR FOLLOWUP  Evaluation for possible device migration, erosion, or other complications - 3 months to 1 year after device closure and periodically thereafter  Device erosion (chest pain or syncope) should warrant urgent evaluation 94
  • 95. ASD: NATURAL HISTORY IN A NUTSHELL 95 Perloff 5th edition